OpenAI has secured Microsoft’s support to convert its for-profit arm into a public benefit corporation, a deal that would ...

Microsoft has signed a deal with Anthropic to use its AI in Office apps, reducing dependence on OpenAI. The move highlights ...

Background The long-acting monoclonal antibody nirsevimab and respiratory syncytial virus (RSV) vaccines became available for prevention of severe RSV-associated disease in 2023. While clinical trials ...